Corvus Pharmaceuticals (CRVS) Change in Acquisitions & Divestments (2015 - 2026)

Corvus Pharmaceuticals' Change in Acquisitions & Divestments history runs 12 years deep, the most recent figure standing at $17.0 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 41.67% year-over-year to $17.0 million; the TTM figure through Mar 2026 stood at $89.1 million (up 78.26% YoY), while the FY2025 annual figure was $84.1 million, up 97.34% from the prior year.
• Change in Acquisitions & Divestments was $17.0 million for Q1 2026 at Corvus Pharmaceuticals, down from $24.3 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $28.5 million in Q3 2025 to a low of $810000.0 in Q1 2022.
• Historically, Change in Acquisitions & Divestments has averaged $14.7 million across 5 years, with a median of $15.4 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Change in Acquisitions & Divestments tumbled 90.08% in 2022, then soared 2088.27% in 2023.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $15.4 million in 2022, then plunged by 40.85% to $9.1 million in 2023, then jumped by 56.73% to $14.3 million in 2024, then soared by 70.41% to $24.3 million in 2025, then sank by 30.18% to $17.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $17.0 million (Q1 2026), $24.3 million (Q4 2025), and $28.5 million (Q3 2025), per Business Quant data.